Carestrean DRX Plus 3543C

Carestream DRX Plus 3543

Fifty-seven percent of American women believe they should receive a mammogram annually, according to the Truven Health Analytics-NPR Health Poll. However, the U.S. Preventive Services Task Force (USPSTF) issued guidance earlier this year which suggested that women should get a mammogram every two years starting at age 50, provided they do not have a family history or find a lump.

NorthStar Medical Radioisotopes LLC has received approval to begin routine production of molybdenum-99 (Mo-99) at the University of Missouri Research Reactor (MURR) facility in Columbia, Missouri.

Novarad has developed its own specialty viewer with advanced hanging protocols and workflows designed especially for digital mammography. While Novarad customers have been using a third-party mammography viewer for years, the new viewer is completely native to the NovaPACS enterprise viewer.

Most people assume strokes only happen to octogenarians, but recent evidence suggests that survivors of childhood cancer have a high risk of suffering a stroke at a surprisingly young age.

HealthMyne, an imaging informatics company, today announced 510(k) clearance from the U.S. Food and Drug Administration (FDA). The new imaging informatics platform is designed to streamline clinical decision support and integrate with enterprise PACS and vendor-neutral archives using industry-standard formats.

The American Society for Radiation Oncology (ASTRO) has selected seven leading physician-researchers to receive a total of $675,000 in awards and grants to advance radiation oncology research.

In the midst of a growing trend for Medicare patients to receive observation care in the hospital to determine if they should be formally admitted, a new study from researchers at the Perelman School of Medicine at the University of Pennsylvania shows that for more than a quarter of beneficiaries with multiple observation stays, the cumulative out-of-pocket costs of these visits exceeds the deductible they would have owed for an inpatient hospital admission.

Women who are obese have a higher risk and a worse prognosis for breast cancer, but the reasons why remain unclear. A Cornell study published this month in Science Translational Medicine explains how obesity changes the consistency of breast tissue in ways that are similar to tumors, thereby promoting disease.

The study of mice and women shows obesity leads to a stiffening of a meshwork of material that surrounds fat cells in the breast, called the extracellular matrix, and these biomechanical changes create the right conditions for tumor growth.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now